Industry Intelligence
Healthcare encompasses a wide range of services, products, and technologies aimed at improving health and well-being. This industry includes pharmaceuticals, medical devices, and nutraceuticals.
Healthy Extracts Inc. has reported a 73% increase in net revenue for Q1 2026, reaching a record $1.6 million, attributed to significant strategic developments.
Microbix Biosystems Inc. has reported a 5% revenue growth in the first half of fiscal 2026 as the company works to overcome previous setbacks. While the results show progress, challenges remain, particularly in antigen sales to China.
BullFrog AI and Bimergen Energy will present interviews on Bloomberg TV discussing their innovative technologies and growth strategies in drug development and energy storage.
Xcelerate, Inc. has divested its majority interest in the ESN Group, shifting focus towards AI-driven healthcare solutions in Africa through its subsidiary, AfiyaSasa Africa, LLC.
ZEO ScientifiX has announced a significant growth milestone, surpassing $1 million in unaudited monthly sales for the first time in April 2026. This achievement underscores the company's effective sales strategy and commitment to physician partnerships.
AI/ML Innovations Inc. announces the addition of Dr. Martin Green to its Medical Advisory Board, enhancing its clinical capabilities in ECG technology, alongside the grant of stock options to its employees.
Integrated BioPharma has reported a significant decline in revenue and a shift to operating losses for the first quarter of 2026 compared to the same period last year. The financial outlook raises concerns for future profitability as the company depends heavily on a small customer base.
Microbix Biosystems Inc. is set to announce its financial results for Q2 fiscal 2026 on May 14, 2026, followed by a webinar featuring discussions with its top executives.
Clyra Medical Technologies has secured an exclusive agreement with Al-Hikma FZCO to distribute ViaCLYR™ throughout the Middle East and North Africa, marking a significant step for Clyra's international expansion.